MedTrace Logo

The Effact of Helicobacter Hylori Eradication on the Development of Gastric Mucosa Pathology

NCT04029441 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2019-07-23

No results posted yet for this study

Summary

Subjects who are included will recieve Hp eradication therapy based on antimicrobial susceptibility test. After the therapy, the subjects will be divided into two groups, the successful group and the failure group. And then they wiil be followed up to observe the development of the gastric mucosa pathology.

Conditions

  • Helicobacter Gastritis

Interventions

OTHER

the eradication Hp

the eradication of Hp based on antimicrobial susceptibility test

Sponsors & Collaborators

  • Shandong University

    lead OTHER

Principal Investigators

  • Xiuli H Zuo · Qilu Hospital of Shandong University

  • Tian H Ma · Qilu Hospital of Shandong University

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-01
Primary Completion
2021-09-30
Completion
2021-09-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04029441 on ClinicalTrials.gov